Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × pralsetinib × 1 year × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Non-Small-Cell Lung 4 Thyroid Neoplasms 3 Thoracic Neoplasms 2 Respiratory Tract Neoplasms 2 Respiratory Tract Diseases 2 Neoplasms, Nerve Tissue 2 Neoplasms, Germ Cell and Embryonal 2 Neoplasms by Site 2 Neoplasms by Histologic Type 2 Neoplasms 2 Lung Neoplasms 2 Lung Diseases 2 Head and Neck Neoplasms 2 Carcinoma, Bronchogenic 2 Carcinoma 2 Adenocarcinoma 2 Thyroid Diseases 1 Thyroid Cancer, Papillary 1 Solid Tumors 1 Neuroendocrine Tumors 1 Neuroectodermal Tumors 1 Neoplasms, Glandular and Epithelial 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 2a 1 Intestinal Neoplasms 1 Intestinal Diseases 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Endocrine System Diseases 1 Endocrine Gland Neoplasms 1

Interventions

pembrolizumab 102 Specimen Handling 52 Magnetic Resonance Spectroscopy 46 Nivolumab 45 Biopsy 45 Paclitaxel 34 Gemcitabine 32 Radiosurgery 28 Carboplatin 28 Ipilimumab 23 trastuzumab deruxtecan 22 Cyclophosphamide 22 Cisplatin 22 Irinotecan 21 Leucovorin 20 Capecitabine 20 Fluorouracil 19 Fulvestrant 18 Bevacizumab 18 Oxaliplatin 17 Drug Therapy 17 Cetuximab 17 130-nm albumin-bound paclitaxel 17 Taxes 16 Pemetrexed 16 Docetaxel 16 atezolizumab 15 Trastuzumab 15 olaparib 14 abemaciclib 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05525858 2025-04-27

KOSMOSII

Seoul National University Bundang Hospital

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡